Entrada Therapeutics, Inc. (TRDA) Investor Relations Documents

Entrada Therapeutics, Inc. (TRDA) investor relations documents from the company's IR site: 1 presentation, 13 press releases; latest deck 2026-08-04. Read in-app with summaries. First-party data.

Entrada Therapeutics Corporate Presentation August 2026: Entrada Therapeutics is advancing a pipeline of genetic medicines for neuromuscular and retinal diseases, with four clinical data catalysts expected in 2026.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-05	Press release	Entrada Therapeutics Reports Second Quarter 2026 Financial Results
2026-08-04	Presentation	Entrada Therapeutics Corporate Presentation August 2026
2026-06-02	Press release	Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entr
2026-06-01	Press release	Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-07	Press release	Entrada Therapeutics Reports First Quarter 2026 Financial Results
2026-05-07	Press release	Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy T
2026-05-06	Press release	Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated
2026-03-02	Press release	Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-02-26	Press release	Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-17	Press release	Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada The
2026-02-04	Press release	Entrada Therapeutics to Present at Upcoming Investor Conferences
	Press release	Entrada Therapeutics Reports Third Quarter 2025 Financial Results
	Press release	Entrada Therapeutics Reports Second Quarter 2025 Financial Results
	Press release	Entrada Therapeutics Reports First Quarter 2025 Financial Results

TRDA overview · TRDA earnings · TRDA financials · TRDA KPIs · TRDA ownership · TRDA peers · TRDA filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.